Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Nosocomial infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have become public-health problem. However, few studies have evaluated the control of endemic MDR A. baumannii in Intensive Care Units (ICUs). Therefore, we investigated the effectiveness of antimicrobial stewardship and comprehensive intensified infection control measures for controlling endemic MDR A. baumannii in ICUs at a tertiary care center. Methods: Carbapenem use was strictly restricted through antimicrobial stewardship. Environmental cleaning and disinfection was performed at least 3 times per day in addition to basic infection control measures. Isolation using plastic curtains and contact precautions were applied to patients who were colonized or infected with MDR A. baumannii. The outcome was measured as the incidence density rate of hospital-onset MDR A. baumannii among patients in the ICUs. Results: The incidence density rate of hospital-onset MDR A. baumannii decreased from 22.82 cases per 1,000 patient-days to 2.68 cases per 1,000 patient-days after the interventions were implemented (odds ratio, 0.12; 95% confidence interval, 0.03 to 0.4; p < 0.001). The mean monthly use of carbapenems also decreased from 134.99 ± 82.26 defined daily doses per 1,000 patient-days to 94.85 ± 50.98 defined daily doses per 1,000 patient-days (p = 0.016). Conclusions: Concomitant implementation of strict antimicrobial stewardship and comprehensive infection control measures effectively controlled endemic MDR A. baumannii in our ICUs within 1 year.
Abstract
Background/Aims: Nosocomial infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have become public-health problem. However, few studies have evaluated the control of endemic MDR A. baumannii in Intensive Care Units (ICUs). Therefore, we investigated the effectiveness of antimicrobial stewardship and comprehensive intensified infection control measures for controlling endemic MDR A. baumannii in ICUs at a tertiary care center. Methods: Carbapenem use was strictly restricted through antimicrobial stewardship. Environmental cleaning and disinfection was performed at least 3 times per day in addition to basic infection control measures. Isolation using plastic curtains and contact precautions were applied to patients who were colonized or infected with MDR A. baumannii. The outcome was measured as the incidence density rate of hospital-onset MDR A. baumannii among patients in the ICUs. Results: The incidence density rate of hospital-onset MDR A. baumannii decreased from 22.82 cases per 1,000 patient-days to 2.68 cases per 1,000 patient-days after the interventions were implemented (odds ratio, 0.12; 95% confidence interval, 0.03 to 0.4; p < 0.001). The mean monthly use of carbapenems also decreased from 134.99 ± 82.26 defined daily doses per 1,000 patient-days to 94.85 ± 50.98 defined daily doses per 1,000 patient-days (p = 0.016). Conclusions: Concomitant implementation of strict antimicrobial stewardship and comprehensive infection control measures effectively controlled endemic MDR A. baumannii in our ICUs within 1 year.
참고문헌 (27)
- Bergogne-Berezin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features", Clin Microbiol Rev, 9, pp.148~165 (1996)
- Bergogne-Berezin E, "Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus", J Hosp Infect, 10, pp.105~113 (1987)
- Gaynes R, "National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli", Clin Infect Dis, 41, pp.848~854 (2005)
- Paul M, "Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002", J Hosp Infect, 60, pp.256~260 (2005)
- Turton JF, "A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England", J Hosp Infect, 58, pp.170~179 (2004)
- Coelho JM, "Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England", J Clin Microbiol, 44, pp.3623~3627 (2006)
- Wendt C, "Survival of Acinetobacter baumannii on dry surfaces", J Clin Microbiol, 35, pp.1394~1397 (1997)
- Karageorgopoulos DE, "Current control and treatment of multidrug-resistant Acinetobacter baumannii infections", Lancet Infect Dis, 8, pp.751~762 (2008)
- 곽이경, "전국병원감염감시체계 중환자실 부문 결과 보고: 2009년 7월부터 2010년 6월", 병원감염관리, 16(1), pp.1~12 (2011), 대한의료관련감염관리학회
- Das I, "Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units", J Hosp Infect, 50, pp.110~114 (2002)
- Enoch DA, "Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK", J Hosp Infect, 70, pp.109~118 (2008)
- Rodriguez-Bano J, "Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach", Am J Infect Control, 37, pp.715~722 (2009)
- La Forgia C, "Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report", Am J Infect Control, 38, pp.259~263 (2010)
- Munoz-Price LS, "Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions", Am J Infect Control, 42, pp.466~471 (2014)
- Cohen AL, "Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA", HICPAC position paper, 2008, pp.29, 901~913
- Horan TC, "CDC", NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, 2008, pp.36, 309~332
- Maxwell M, "General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method", BMJ, 307, pp.1190~1194 (1993)
- Lee SO, "Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii:a case-control study", Antimicrob Agents Chemother, 48, pp.224~228 (2004)
- Lautenbach E, "Epidemiology and impact of imipenem resistance in Acinetobacter baumannii", Infect Control Hosp Epidemiol, 30, pp.1186~1192 (2009)
- Su CH, "Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage", PLoS One, 7, pp.e37788~ (2012)
- Ogutlu A, "Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients", Ann Clin Microbiol Antimicrob, 13, pp.7~ (2014)
- Lefebvre A, "Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii:a 10-year multi-department study", Am J Infect Control, 39, pp.891~894 (2011)
- Boyce JM, "Environmental contamination makes an important contribution to hospital infection", J Hosp Infect, 65(Suppl 2), pp.50~54 (2007)
- Dancer SJ, "The role of environmental cleaning in the control of hospital-acquired infection", J Hosp Infect, 73, pp.378~385 (2009)
- Hess AS, "A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria", Infect Control Hosp Epidemiol, 34, pp.487~493 (2013)
- Hayden MK, "Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures", Clin Infect Dis, 42, pp.1552~1560 (2006)
- Eckstein BC, "Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods", BMC Infect Dis, 7, pp.61~ (2007)